Gilead Sciences, Inc.

NASDAQ:GILD   3:59:59 PM EDT
69.70
+0.77 (+1.12%)
Products

Gilead Submits Biologics License Application To FDA For Bulevirtide

Published: 11/19/2021 13:12 GMT
Gilead Sciences, Inc. (GILD) - Gilead Submits Biologics License Application to U.S. Food and Drug Administration for Bulevirtide, an Investigational Treatment for People Living With Chronic Hepatitis Delta.
Gilead Submits Biologics License Application to U.S. Food and Drug Administration for Bulevirtide, an Investigational Treatment for People Living With Chronic Hepatitis Delta.